Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics

L Migliore, F Coppedè - Nature Reviews Neurology, 2022 - nature.com
With the exception of a few monogenic forms, Alzheimer disease (AD) has a complex
aetiology that is likely to involve multiple susceptibility genes and environmental factors. The …

An overview of recent analysis and detection of acetylcholine

X Gu, X Wang - Analytical Biochemistry, 2021 - Elsevier
Acetylcholine (ACh), the major neurotransmitter secreted by cholinergic neurons, is widely
found in the peripheral and central nervous systems, and its main function is to complete the …

Recent advances in the discovery of nicotinic acetylcholine receptor allosteric modulators

D Manetti, S Dei, HR Arias, L Braconi, A Gabellini… - Molecules, 2023 - mdpi.com
Positive allosteric modulators (PAMs), negative allosteric modulators (NAMs), silent
agonists, allosteric activating PAMs and neutral or silent allosteric modulators are …

[HTML][HTML] Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors

C Matera, C Papotto, C Dallanoce… - Pharmacological Research, 2023 - Elsevier
The study of nicotinic acetylcholine receptors (nAChRs) has significantly progressed in the
last decade, due to a) the improved techniques available for structural studies; b) the …

Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models

LC Smith, O George - Neuropharmacology, 2020 - Elsevier
The landscape of worldwide tobacco use is changing, with a decrease in traditional smoking
and an exponential rise in electronic cigarette use. No new nicotine cessation …

Potentiation of (α4) 2 (β2) 3, but not (α4) 3 (β2) 2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms

AK Hamouda, MR Bautista, LS Akinola, Y Alkhlaif… - …, 2021 - Elsevier
Abstract The low sensitivity (α4) 3 (β2) 2 (LS) and high sensitivity (α4) 2 (β2) 3 (HS) nAChR
isoforms may contribute to a variety of brain functions, pathophysiological processes, and …

Pyrrolidinyl benzofurans and benzodioxanes: Selective α4β2 nicotinic acetylcholine receptor ligands with different activity profiles at the two receptor stoichiometries

R Appiani, M Pallavicini, AK Hamouda… - Bioorganic & Medicinal …, 2022 - Elsevier
A series of racemic benzofurans bearing N-methyl-2-pyrrolidinyl residue at C (2) or C (3) has
been synthesized and tested for affinity at the α4β2 and α3β4 nicotine acetylcholine …

Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies

E Montigné, D Balayssac - Pharmaceuticals, 2023 - mdpi.com
Neuropathic pain affects about 7–8% of the population, and its management still poses
challenges with unmet needs. Over the past decades, researchers have explored the …

Anti-hyperalgesic and anti-inflammatory effects of 4R-tobacco cembranoid in a mouse model of inflammatory pain

LG Rivera-García, AM Francis-Malavé, ZW Castillo… - Journal of …, 2024 - Springer
Abstract 4R is a tobacco cembranoid that binds to and modulates cholinergic receptors and
exhibits neuroprotective and anti-inflammatory activity. Given the established function of the …

Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and …

R Nirogi, R Abraham, P Jayarajan, V Goura… - …, 2022 - Springer
Abstract Rationale Ropanicant (SUVN-911)(3-(6-Chloropyridine-3-yloxymethyl)-2-
azabicyclo (3.1. 0) hexane hydrochloride) is a novel α4β2 nicotinic acetylcholine receptor …